Abercrombie & Fitch Co. (ANF) Guidance & Earnings Results

On 2026-08-26 Abercrombie & Fitch Co. raised guidance: "FY26 net sales growth ~5% (prior ~4-5%? not stated); FY26 EPS $13.10-$13.60 (prior not stated); Q3 net sales growth 5-6%, EPS $2.90-$3.20; share repurchases increased to at least $500M from prior $400M? not…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason

ANFAbercrombie & Fitch Co.Follow ANF — free

Apparel Retail · Consumer Cyclical

—

Price chart with a free account

Market cap: 6.6B
P/E TTM: 13.4
Dividend yield: —
52-week: —
Next earnings: 23 Nov, in 30 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
26 Aug 26	Raised	FY26 net sales growth ~5% (prior ~4-5%? not stated); FY26 EPS $13.10-$13.60 (prior not stated); Q3 net sales growth 5-6%, EPS $2.90-$3.20; share repurchases increased to at least $500M from prior $400M? not stated
27 May 26	Reaffirmed	Full-year net sales growth 3-5%, EPS $10.20-$11.00 · full year
4 Mar 26	Reaffirmed	FY2026 net sales growth 3-5%, operating margin 12-12.5%, EPS $10.20-$11.00. · full year
26 Nov 25	Raised	FY net sales growth 6-7% (narrowed); EPS $10.20-$10.50 · full year
28 Aug 25	Raised	Increased full-year net sales outlook; profitability update incorporates $90M net tariff cost estimate · full year

Abercrombie & Fitch Co. — questions

What guidance did Abercrombie & Fitch Co. give?: On 2026-08-26: "FY26 net sales growth ~5% (prior ~4-5%? not stated); FY26 EPS $13.10-$13.60 (prior not stated); Q3 net sales growth 5-6%, EPS $2.90-$3.20; share repurchases increased to at least $500M from prior $400M? not stated"
When does Abercrombie & Fitch Co. report earnings?: Abercrombie & Fitch Co.'s next earnings report is expected on 2026-11-23.

Every figure on this page comes from Abercrombie & Fitch Co.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.